BASE receives ARC funding to improve mRNA quality control

News - June 27, 2024

In partnership with Oxford Nanopore Technologies, BASE has been awarded funding from the Australian Research Council (ARC) to routinely integrate nanopore sequencing into mRNA manufacturing processes.

Back to news

Latest news from BASE

4th QLD mRNA Symposium

On International RNA Day (1 August), the BASE facility hosted the 4th QLD mRNA Symposium, bringing together leading experts from research, clinical, government, and industry to discuss advances in mRNA medicines.

Learn more

mRNA-LNP masterclass

Our graduates successfully completed the first Winter mRNA Masterclass, a week-long intensive program that trains students in the science, computational design, and laboratory production of mRNAs and LNPs.

Learn more

Our workflow published

We published our step-by-step protocol for mRNA-LNP production, describing the design, manufacture, and quality control of mRNA medicines using standard equipment in a research laboratory.

Learn more

Rapid mRNA Production

Over the past three years, we have established an end-to-end manufacturing work flow for the high-throughput production of mRNA-LNPs. Our advanced processes enable the rapid and reliable manufacture of high-quality mRNA-LNPs. These processes include cell-free DNA template production, automated liquid handling, and a quality management system.

Enquiries

Our team is available to help with your mRNA projects.